-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical Network Enterprise News: Zixin Pharmaceuticals announced on the evening of February 4that that the company's liquid disinfectant products "75% ethanol disinfectant" was recently issued by Jilin Provincial Health and Health Committee of the "sanitation license for disinfection products production enterprises." To be filed after the company will be in strict accordance with the relevant regulatory requirements to put into production, increase market supply, alleviate the epidemic prevention process of disinfectant supply shortage
According to the "New Coronary Virus Infection Pneumonia Diagnosis and Treatment Program (Trial 4th Edition) issued by the General Office of the National Health and Health Commission and the Office of the State Administration of Traditional Chinese Medicine), 75% of sterilizing products such as ethanol, chlorine-containing disinfectants and peroxyacetic acid can effectively inactivate the virus
It is understood that at present, due to the market epidemic prevention and control supplies increased sharply, some areas of the supply of disinfectant tight situationIn order to alleviate the urgent need, on February 4, the General Office of the National Health and Reform Commission issued a notice on the emergency marketing of some disinfectants during the prevention and control of the pneumonia outbreak of the new coronary virus infection
It is reported that, as a major pharmaceutical province, Jilin Province is accelerating actionAfter communication and coordination and policy guidance, the provincial Drug Administration and the province's medical device enterprises, including Zixin Pharmaceuticals, enterprises in the registration declaration and preparation of the production of masks, protective clothing and other epidemic prevention and control related products, enjoy the Jilin Provincial Drug Administration green approval channel related policiesThese enterprises declare registered epidemic prevention products recently put into production, will further alleviate the shortage of medical products
This Zixin Pharmaceuticals timely access to 75% ethanol disinfection liquid license, will be expected to put into production as soon as possible to alleviate the shortage of market supply
The author learned that Zixin Pharmaceuticals revealed on February 2nd that the company had decided to donate more than 200 million yuan worth of urgently needed medicines to the hard-hit hubei and Wuhan regions in accordance with the development of the epidemic to jointly combat the epidemic
In addition, Zixin Pharmaceuticals has also been the company's inventory and multi-funded 10,000 sets of protective clothing, goggles, masks and dozens of tons of alcohol and other medical materials donated to Jilin Province and the country's more affected areas of medical institutions, for the local shortage of medical supplies to alleviate the urgency
Data show that Zixin Pharmaceutical son-in-line medicine started, has gradually developed into an industry-influenced pharmaceutical listed group, which has accumulated profound development advantages in the field of traditional Chinese medicine and ginseng, and in the field of industrial cannabis in advance layout, forming a ginseng, Traditional Chinese medicine, industrial cannabis co-development of the industrial ecology
It is worth mentioning that on the evening of February 3, Zixin Pharmaceuticalissue issued a notice that the board of directors voted to consider and approve the "on increasing the scope of business and amendment of the bill", agreed to increase the scope of business: medical equipment research and development, production and sales; Agree that the Company shall make corresponding amendments to the Articles of Association in accordance with the change spree of the Business Scope
Industry analysis pointed out that Zixin Pharmaceutical sopens the scope of business, take the initiative to assume the relevant business production, for the later medical devices will play a very good complementary role
Zixin Pharmaceutical son," Zixin Pharmaceutical son, said, as a pharmaceutical enterprise, into the community, give back to the community has been the direction of the company' commitment, the company will mobilize all resources within the enterprise, to ensure the timely supply of drugs and materialsIn the future, the company will also pay close attention to the development of the epidemic, for the public, especially the people in the outbreak of more help.